科普文章
查看全部 ![](https://jkimg11.360buyimg.com/imagetools/jfs/t1/107662/32/40681/858/643779baFc3c66cbf/6de8da20b882d771.png)
- 全部科室
- 内科
- 中医科
- 皮肤性病科
- 儿科
- 妇产科
- 外科
- 男科
- 骨科
- 精神心理科
- 营养科
- 全科
- 耳鼻咽喉头颈外科
- 眼科
- 口腔科
- 小儿外科
- 儿童保健科
- 肿瘤科
- 中西医结合科
- 预防保健科
- 医学影像科
- 医疗美容科
- 康复医学科
- 药学门诊
- 疼痛科
- 传染科
- 民族医学科
- 病理科
- 其他科
![](http://image.healthjd.com/da/s100x100_jfs/t1/228421/8/20755/481/6684f9f2Fdf5af469/dc8a2662f79d2217.jpg!q100)
以下内容来源于pubmed。 Histologic Remission in Inflammatory Bowel Disease and Female Fertility: A Nationwide Study Abstract Background & aims: Inflammatory bowel disease (IBD) is linked to reduced female fertility, but it is unclear how fertility rates vary by histologic disease activity. Methods: Nationwide IBD cohort of Swedish women aged 15 to 44 years. We examined fertility rates during periods with vs without histologic inflammation (n = 21,046; follow-up, 1990-2016) and during periods with vs without clinical activity (IBD-related hospitalization, surgery, or treatment escalation) (n = 24,995; follow-up, 2006-2020). Accounting for sociodemographics and comorbidities, we used Poisson regression to estimate adjusted fertility rate ratios (aFRRs) for live births conceived during 12-month periods of histologic inflammation (vs histologic remission) and 3-month periods of clinically active IBD (vs quiescent IBD). Results: During periods with vs without histologic inflammation, there were 6.35 (95% confidence interval [CI], 5.98-6.73) and 7.09 (95% CI, 6.48-7.70) live births conceived per 100 person-years of follow-up, respectively, or 1 fewer child per 14 women with 10 years of histologic inflammation (aFRR, 0.90; 95% CI, 0.81-1.00). In women with histologic inflammation, fertility was similarly reduced in ulcerative colitis (UC) (aFRR, 0.89 [95% CI, 0.78-1.02]) and Crohn's disease (CD) (aFRR, 0.86 [95% CI, 0.72-1.04]). Clinical IBD activity was associated with an aFRR of 0.76 (95% CI, 0.72-0.79) or 1 fewer child per 6 women with 10 years of clinical activity. Fertility was reduced in clinically active UC (aFRR, 0.75 [95% CI, 0.70-0.81]) and CD (aFRR, 0.76 [95% CI, 0.70-0.82]). Finally, among women with clinically quiescent IBD, histologic inflammation (vs histologic remission) was associated with reduced fertility (aFRR, 0.85 [95% CI, 0.73-0.98]). Conclusions: An association between histologic and clinical activity and reduced female fertility in CD and UC was found. Notably, histologic inflammation was also linked to reduced fertility in women with clinically quiescent IBD. Keywords: Histology; Population-Based; Remission. Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
![](http://image.healthjd.com/da/s100x100_jfs/t1/242868/6/11612/495/6684f685F9f21dbdf/2173f44a77a64435.jpg!q100)
点击查看
![](https://jkimg11.360buyimg.com/imagetools/jfs/t1/107662/32/40681/858/643779baFc3c66cbf/6de8da20b882d771.png)
以下内容来源于pubmed。 When cardiovascular medicines should be discontinued Abstract An integral component of the practice of medicine is focused on the initiation of medications, based on clinical practice guidelines and underlying trial evidence, which usually test the addition of novel medications intended for life-long use in short-term clinical trials. Much less attention is given to the question of medication discontinuation, especially after a lengthy period of treatment, during which patients age gets older and diseases may either progress or new diseases may emerge. Given the paucity of data, clinical practice guidelines offer little to no guidance on when and how to deprescribe cardiovascular medications. Such decisions are often left to the discretion of clinicians, who, together with their patients, express concern of potential adverse effects of medication discontinuation. Even in the absence of adverse effects, the continuation of medications without any proven effect may cause harm due to drug-drug interactions, the emergence of polypharmacy, and additional preventable spending to already strained health systems. Herein, several cardiovascular medications or medication classes are discussed that in the opinion of this author group should generally be discontinued, either for the prevention of potential harm, for a lack of benefit, or for the availability of better alternatives.
![](http://image.healthjd.com/da/s100x100_jfs/t1/232646/30/21043/473/6684f45bF90bc0851/eb487af615225c79.jpg!q100)
点击查看
![](https://jkimg11.360buyimg.com/imagetools/jfs/t1/107662/32/40681/858/643779baFc3c66cbf/6de8da20b882d771.png)